| abstract |
The invention relates to the use of PDE2 inhibitors to treat central and peripheral nervous system disorders, a method of treatment therapeutic by administration in an animal of these inhibitors. She relates more specifically to new benzodiazepinone derivatives and their applications in the therapeutic field, particularly for treatment of pathologies involving the activity of a phosphodiesterase type 2 cyclic nucleotides. It also relates to methods for their preparation and new synthesis intermediaries. |